A participant in the company’s late-stage coronavirus vaccine trial reportedly developed severe neurological symptoms. Now experts must assess whether the vaccine was responsible.
Published: September 10, 2020 at 12:37PM
from NYT Health https://ift.tt/3bLNuOZ